Send feedback

ACTN2 p.Ala646=

c.1938C>T · rs958797222 · VCV1097284

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00212%, nfe)
Conditions
3
Cardiovascular phenotype

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.1GERP 1.4, phastCons 1
Overall
CADD13.07PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00212% European (non-Finnish) · 25/1,180,050 alleles
Filtering AF 0.00145% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00123%
Overall 0.00167% 27/1,614,038 alleles · very rare exomes 25/1,461,818 · genomes 2/152,220 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00212% 47,202
Remaining individualsnot grpmax-eligible 0.0016% 62,490
African / African-American 0.00133% 74,942

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ACTN2
Protein
p.Ala646=
Coding
c.1938C>T
MANE Select
NM_001103
dbSNP
rs958797222
Type
single nucleotide variant
Location
chr1:236754045 (GRCh38)
Gene constraint
LOEUF 0.432 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 84.88 · 18 PDB
Full ACTN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/actn2-p-ala646 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown